|
Epitope Discovery
Beckman Coutler's iTopia™ Epitope Discovery System can predict immune response in vaccine characterization and design. By mimicking in vivo peptide binding, an early indicator immune response, iTopia enables researchers to make better decisions earlier in the vaccine design and dvelpoment process. iTopia can quickly and accurately identify immunogenic epitopes from a protein of interest, bringing efficiency and specificity to vaccine desing and development.
iTAg™ MHC Tetramer Technology
Prior to the development of Class I and Class II MHC Tetramers, identification of antigen-specific T cells was limited due to lack of sensitivity and specificity in existing technology. Now with our unparalleled iTAg MHC Tertramer technology, MHC/peptide binding is utilized to detect antigen and MHC-specific T cells at the single-cell level. The immune response information iTAg MHC Tetramers provides is pivotal in helping make the right decisions during vaccine and drug development as well as clinical trials.
|
